Key result
Endoscopic AVR with trans-aortic mitral repair achieves residual MR ≤ 1+ in early series.
Why the study?
Totally endoscopic surgery for aortic valve replacement with concomitant mitral valve repair has not been tested despite the frequent coexistence of mitral regurgitation with aortic valve disease.
Case Report (n=13)
No
BACKGROUND: Minimally invasive aortic valve procedures through a hemi-sternotomy or a right anterior mini-thoracotomy have gained popularity over the last several years. Totally endoscopic aortic valve replacement (TEAVR) is an innovative and a less invasive (incision-wise) surgical aortic valve replacement technique. The operative steps of TEAVR have been reported previously from our group. Mitral regurgitation (MR) frequently accompanies aortic valve disease that at times may also require repair. Totally endoscopic surgery in such cases has not been tested. PRESENTATION OF THE TECHNIQUE: We present a surgical technique for a totally endoscopic approach to aortic valve replacement and concomitant mitral valve repair for primary and secondary MR. An aortotomy incision was used avoiding an atriotomy, which results in an increase in cross-clamp (XC) and cardiopulmonary bypass (CPB) times that could be associated with higher mortality and morbidity. Neochords (artificial chordae tendineae) were used for primary MR and an edge-to-edge approach for secondary MR. CONCLUSION: TEAVR and concomitant mitral valve repair can be performed successfully with reasonable XC and CPB times with excellent short-term results.
No takes yet. Share an insight, caveat, or question.
Pitsis et al. (2021) conducted a case report in Aortic valve disease with concomitant mitral regurgitation (n=13). Totally endoscopic aortic valve replacement (TEAVR) with concomitant trans-aortic mitral valve repair was evaluated on Postoperative mitral regurgitation grade. Totally endoscopic aortic valve replacement with concomitant trans-aortic mitral valve repair was successfully performed in 13 patients, resulting in excellent short-term outcomes with mitral regurgitation ≤ 1+.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: